Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) reached a new 52-week high during trading on Wednesday . The company traded as high as $8.46 and last traded at $8.45, with a volume of 1013 shares changing hands. The stock had previously closed at $8.31. Analyst Upgrades and Downgrades EKTAY has been the subject of a […]
Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 13,400 shares, an increase of 76.3% from the March 15th total of 7,600 shares. Based on an average daily trading volume, of 9,900 shares, the short-interest ratio […]
Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) and MedTech Acquisition (NASDAQ:MTAC – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and institutional ownership. Institutional and Insider Ownership 74.9% of MedTech Acquisition shares […]
Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) – Jefferies Financial Group increased their FY2025 EPS estimates for shares of Elekta AB (publ) in a note issued to investors on Friday, March 31st. Jefferies Financial Group analyst M. Toomey now expects that the company will earn $0.40 per share for the year, up from their prior […]
Elekta AB (publ) (OTCMKTS:EKTAY – Get Rating) was the target of a significant drop in short interest in May. As of May 31st, there was short interest totalling 21,300 shares, a drop of 37.9% from the May 15th total of 34,300 shares. Based on an average daily trading volume, of 116,300 shares, the days-to-cover ratio […]